Congressional trades by ticker
ABBV congressional trades
- Verified rows
- 33
- Filers
- 11
- Purchases
- 19
- Latest trade
- 2026-05-05
Verified ABBV House disclosures
Parsed from official House Clerk periodic transaction reports. This snapshot contains 19 purchases and 14 sales. Reported owners: Joint, Self, Spouse, Dependent. Transaction dates run from 2024-09-26 to 2026-05-05.
| Politician | Trade date | Asset | Type | Owner | Amount | Filing |
|---|---|---|---|---|---|---|
| Josh Gottheimer | AbbVie Inc. Common Stock | Sale | Joint | $1,001 - $15,000 | #20034693 Filed 2026-06-03 | |
| Julie Johnson | AbbVie Inc. Common Stock | Sale | Joint | $1,001 - $15,000 | #20033789 Filed 2026-01-15 | |
| Julia Letlow | AbbVie Inc. Common Stock | Sale | Self | $1,001 - $15,000 | #20030977 Filed 2026-01-13 | |
| Julie Johnson | AbbVie Inc. Common Stock | Sale | Joint | $1,001 - $15,000 | #20033611 Filed 2025-12-11 | |
| Lisa McClain | AbbVie Inc. Common Stock | Sale | Spouse | $1,001 - $15,000 | #20033446 Filed 2025-11-21 | |
| Lisa McClain | AbbVie Inc. Common Stock | Sale | Spouse | $1,001 - $15,000 | #20033446 Filed 2025-11-21 | |
| Lisa McClain | AbbVie Inc. Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20033446 Filed 2025-11-21 | |
| Julie Johnson | AbbVie Inc. Common Stock | Sale | Joint | $1,001 - $15,000 | #20032066 Filed 2025-09-11 | |
| Marjorie Greene | AbbVie Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20030924 Filed 2025-08-15 | |
| Lisa McClain | AbbVie Inc. Common Stock | Sale | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| Lisa McClain | AbbVie Inc. Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| Ritchie Torres | C: This investment is held within a publicly available, widely held independently managed portfolio over which I have no authority to exercise control over or influence the financial interests held by the portfolio. The assets of the portfolio are widely diversified, and all investment decisions are made solely by the independent manager, without my input or direction. AbbVie Inc. Common Stock | Sale | Self | $1,001 - $15,000 | #20030930 Filed 2025-08-20 | |
| Lisa McClain | AbbVie Inc. Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| Josh Gottheimer | AbbVie Inc. Common Stock | Purchase | Joint | $1,001 - $15,000 | #20030462 Filed 2025-06-11 | |
| Robert Bresnahan | AbbVie Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20030482 Filed 2025-06-09 | |
| Marjorie Greene | AbbVie Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20030295 Filed 2025-05-06 | |
| Julia Letlow | AbbVie Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20030977 Filed 2026-01-13 | |
| Josh Gottheimer | AbbVie Inc. Common Stock | Sale | Joint | $1,001 - $15,000 | #20030338 Filed 2025-05-14 | |
| Jefferson Shreve | AbbVie Inc. Common Stock | Sale | Self | $50,001 - $100,000 | #20030231 Filed 2025-05-08 | |
| Robert Bresnahan | AbbVie Inc. Common Stock | Sale | Self | $1,001 - $15,000 | #20030291 Filed 2025-05-08 | |
| Jared Moskowitz | AbbVie Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20030282 Filed 2025-05-09 | |
| Josh Gottheimer | AbbVie Inc. Common Stock | Purchase | Joint | $1,001 - $15,000 | #20030338 Filed 2025-05-14 | |
| Dwight Evans | AbbVie Inc. Common Stock | Sale | Self | $1,001 - $15,000 | #20030179 Filed 2025-04-17 | |
| Josh Gottheimer | AbbVie Inc. Common Stock | Purchase | Joint | $1,001 - $15,000 | #20030338 Filed 2025-05-14 | |
| Marjorie Greene | AbbVie Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20028002 Filed 2025-03-19 | |
| Robert Bresnahan | AbbVie Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20029034 Filed 2025-03-27 | |
| Jefferson Shreve | AbbVie Inc. Common Stock | Purchase | Self | $50,001 - $100,000 | #20027879 Filed 2025-03-09 | |
| Julia Letlow | AbbVie Inc. Common Stock | Sale | Self | $1,001 - $15,000 | #20030977 Filed 2026-01-13 | |
| Jared Moskowitz | AbbVie Inc. Common Stock | Purchase | Dependent | $1,001 - $15,000 | #20026731 Filed 2025-02-10 | |
| Jared Moskowitz | AbbVie Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20026731 Filed 2025-02-10 | |
| Virginia Foxx | AbbVie Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20026516 Filed 2025-01-06 | |
| Julia Letlow | AbbVie Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20030977 Filed 2026-01-13 | |
| Ritchie Torres | AbbVie Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20030930 Filed 2025-08-20 |
A filing can describe the member, a spouse, a dependent, or a joint asset. Amounts are statutory ranges, not execution prices. See how to read congressional stock-trade disclosures before treating a delayed row as a trading signal.
The filing is free
Keep the ABBV range and owner as filed. Membership adds the investment view around the money, not a list to copy.
Related research
ABBV congressional trades — FAQ
Who in Congress traded ABBV?
House Clerk periodic reports for 2025 and 2026 contain 33 verified ABBV rows from 11 members: Dwight Evans, Jared Moskowitz, Jefferson Shreve, Josh Gottheimer, and 7 other members. Image-only filings are excluded, and this is not a live brokerage statement.
Does this page show current ABBV holdings?
No. STOCK Act filings disclose reportable transactions after the fact, usually within 45 days, as amount ranges and owners. They do not prove a current position, an exact share count, or why the trade happened.
Why are ABBV amounts shown as ranges?
House periodic transaction reports use statutory value bands such as $1,001 - $15,000; $50,001 - $100,000. Yield Theory keeps those ranges instead of inventing a midpoint, exact trade size, or return.
How complete is ABBV congressional-trade coverage?
This snapshot covers every machine-readable House periodic transaction report for 2025 and 2026 (142 members). Image-only filings and Senate eFD filings are not included, so missing rows are not proof that no other lawmaker traded ABBV.
Yield Theory is not affiliated with any elected official. This page uses the 2025–2026 House Clerk periodic report snapshot generated 2026-09-20. It is not a complete lifetime portfolio, a performance track record, or investment advice.
A disclosure is not a thesis.
This page shows who reported ABBV and in what range. Membership is the monthly sourced call, plus a five-minute check when the evidence moves. $15/month or $150/year.
$15/mo or $150/yr · cancel future renewals anytime · sources included